Cancer data registry for patients in the U.S.
Part of Blood & lymphatic, Cancer clinical trials.
This study collects information from people with cancer to help researchers learn more about the disease. You may join a general cancer registry or, if your child has a specific type of leukemia, a special part of the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis (any type, any age).
- You receive care in the United States or its territories.
- You or your legal guardian can provide electronic consent.
- You allow access to your medical records.
- You have a smartphone, tablet, or computer to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from young people with a type of blood cancer called acute myeloid leukemia (AML). The goal is to learn more about the disease and improve future treatments. If you are under 25 and being treated for AML at a hospital in France, you might be able to join.
This research study follows young people (babies through age 21) who have been diagnosed with cancer and are currently receiving treatment or in follow-up care. The study aims to better understand their care experiences and outcomes.
This trial gathers information from your routine cancer care to help researchers learn more about real-world treatments and outcomes. No extra tests or procedures are required.
This study looks back at the medical records of children and young adults diagnosed with cancer in the last 15 years. It helps researchers understand more about cancer in young people.
This study enrolls adults with acute myeloid leukemia (AML) to build a detailed registry and store biological samples. It helps researchers understand AML better and may support future studies.
This is a research registry that collects information and lab/blood sample data to better understand what acute leukemia looks like biologically and how patients do over time. It may help future treatment decisions, but it does not describe testing a new drug.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.